Asset Management One
PCRX icon

Asset Management One’s Pacira BioSciences PCRX Stock Holding History

Asset Management One’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-11,832
Closed -$939K – 1339
2015
Q4 		$939K Sell
11,832
-70,804
-86% -$4.01M 0.01% 885
2015
Q3 		$3.5M Sell
82,636
-124,859
-60% -$7.65M 0.05% 437
2015
Q2 		$14.1M Buy
207,495
+58,206
+39% +$4.58M 0.19% 117
2015
Q1 		$13.5M Buy
149,289
+41,878
+39% +$4.25M 0.17% 141
2014
Q4 		$10.1M Buy
107,411
+46,610
+77% +$4.41M 0.13% 193
2014
Q3 		$6.03M Buy
60,801
+58,684
+2,772% +$5.71M 0.08% 288
2014
Q2 		$192K Buy
+2,117
New +$161K ﹤0.01% 1089
2014
Q1 		– Sell
-9,421
Closed -$534K – 1158
2013
Q4 		$534K Sell
9,421
-3,710
-28% -$195K 0.01% 916
2013
Q3 		$625K Buy
+13,131
New +$479K 0.01% 871

Other funds holding PCRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Asset Management One's PCRX Position: Q1 2016 in Review

Asset Management One sold out of Pacira BioSciences (PCRX) in Q1 2016, closing a stake of 11,832 shares — an estimated $939K sold.

Asset Management One first reported a position in PCRX in Q3 2013 and held it in 9 quarters. The position peaked at $14.1M in Q2 2015. 180 funds tracked by Wall St. Rank hold PCRX as of Q1 2016.

  • Asset Management One reported no remaining Pacira BioSciences position as of Q1 2016 after selling out during the quarter.
  • Asset Management One sold 11,832 Pacira BioSciences shares in Q1 2016, an estimated $939K.
  • Asset Management One first reported a position in Pacira BioSciences in Q3 2013 and held it in 9 quarters.
  • Asset Management One's Pacira BioSciences position peaked at $14.1M in Q2 2015.
  • 180 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2016.

Based on Asset Management One's 13F filing for Q1 2016, filed 5 May 2016.